Comparative Study
Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry
- PMID: 16355556
Item in Clipboard
Comparative Study
Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry
J Support Oncol.
2005 Nov-Dec.
No abstract available
Similar articles
-
Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.Oncol Nurs Forum. 2006 Nov 3;33(2):347-52. doi: 10.1188/06.ONF.347-352. Oncol Nurs Forum. 2006. PMID: 16518450
-
Best practices in neutropenia management: you can get there from here.J Support Oncol. 2005 Nov-Dec;3(6 Suppl 4):26-7. J Support Oncol. 2005. PMID: 16355557 No abstract available.
-
Improving the management of chemotherapy-induced neutropenia.J Support Oncol. 2004 Mar-Apr;2(2 Suppl 2):36-9. J Support Oncol. 2004. PMID: 16108418 No abstract available.
-
Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?Lung Cancer. 2009 Oct;66(1):8-14. doi: 10.1016/j.lungcan.2009.02.022. Epub 2009 Mar 27. Lung Cancer. 2009. PMID: 19328587 Review.
-
Risk assessment in fever and neutropenia in children with cancer: What did we learn?Crit Rev Oncol Hematol. 2009 Oct;72(1):45-55. doi: 10.1016/j.critrevonc.2008.12.009. Epub 2009 Feb 4. Crit Rev Oncol Hematol. 2009. PMID: 19195908 Review.
Cited by
-
Burden, risk factors, and management of neutropenic fever among solid cancer patients in Ethiopia.SAGE Open Med. 2022 May 19;10:20503121221098236. doi: 10.1177/20503121221098236. eCollection 2022. SAGE Open Med. 2022. PMID: 35646361 Free PMC article.
-
Compatibility of Biosimilar Filgrastim with Cytotoxic Chemotherapy during the Treatment of Malignant Diseases (VENICE): A Prospective, Multicenter, Non-Interventional, Longitudinal Study.Adv Ther. 2016 Nov;33(11):1983-2000. doi: 10.1007/s12325-016-0419-1. Epub 2016 Oct 14. Adv Ther. 2016. PMID: 27743353 Free PMC article.
-
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.BMC Cancer. 2010 Nov 23;10:642. doi: 10.1186/1471-2407-10-642. BMC Cancer. 2010. PMID: 21092320 Free PMC article.
-
Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.Breast Care (Basel). 2021 Feb;16(1):50-58. doi: 10.1159/000506622. Epub 2020 Apr 6. Breast Care (Basel). 2021. PMID: 33716632 Free PMC article.
-
Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study.Support Care Cancer. 2016 May;24(5):1991-1998. doi: 10.1007/s00520-015-2986-0. Epub 2015 Oct 27. Support Care Cancer. 2016. PMID: 26507190 Free PMC article.